pharma · Multiple Myeloma · Relapsed/Refractory Multiple Myeloma
Janssen-Cilag International N.V
Janssen-Cilag International N.V.
Janssen-Cilag International N.V clinical programs — 161 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- São Paulo, EU
- Employees
- 13
- Programs
- 161
- Drugs
- 159
- Patents
- 0
Janssen-Cilag International N.V projects
161 ClinicalTrials.gov programs sponsored by Janssen-Cilag International N.V.
Janssen-Cilag International N.V has 161 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
A Multi-arm Phase 1b Study of Teclistamab Wit...
Janssen-Cilag International N.V.
Relapsed/Refractory Multiple Myeloma
1 trial -
A Phase 1 Study of JNJ-79032421 Targeting Mes... for Advanced Stage Solid Tumors
Janssen-Cilag International N.V.
Advanced Stage Solid Tumors
1 trial -
A Phase 1 Study of JNJ-87562761 in Relapsed/Refractory Multiple Myeloma
Janssen-Cilag International N.V.
Relapsed/Refractory Multiple Myeloma
1 trial -
A Phase 1 Study of JNJ-87801493 in Combination with CD3 T-Cell Engagers
Janssen-Cilag International N.V.
Non-Hodgkin Lymphoid Malignancies
1 trial -
A Phase 1 Study of JNJ-87890387 for Advanced Solid Tumors
Janssen-Cilag International N.V.
Advanced Solid Tumors
1 trial -
A Phase 1 for Advanced Non-Small Cell Lung Cancer
Janssen-Cilag International N.V.
Advanced Non-Small Cell Lung Cancer
1 trial -
A Phase 1 for Relapsed/refractory B-cell Non…
Janssen-Cilag International N.V.
Relapsed/refractory B-cell Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
1 trial -
A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors
Janssen-Cilag International N.V.
Locally advanced, metastatic NSCLC, CRC, or HNSCC that has recurred or progressed after prior stand of care therapy
1 trial -
A study to assess the effect of single and re... for Plaque Psoriasis
Janssen-Cilag International N.V.
Plaque Psoriasis
1 trial -
A study to compare the amount of milvexian in...
Janssen-Cilag International N.V.
atherothrombotic and thromboembolic disorders
1 trial -
A study to evaluate how the body absorbs for Healthy Volunteers
Janssen-Cilag International N.V.
Healthy Volunteers
1 trial -
Characterization of Immune Response in Participants from a Posdinemab Study
Janssen-Cilag International N.V.
Early Alzheimer's disease
1 trial -
PLATFORMPACAN1001
Janssen-Cilag International N.V.
Non-Hodgkin lymphoma and chronic lymphocytic leukemia
1 trial -
Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs
Janssen-Cilag International N.V.
Non-Hodgkin Lymphoid Malignancies (NHLs)
1 trial -
Phase 1 Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancer
Janssen-Cilag International N.V.
Metastatic colorectal cancer and Gastric cancer
1 trial -
TMC207TBC1006
Janssen-Cilag International N.V.
Tuberculosis
1 trial -
CNTO1959PSA4002
Janssen-Cilag International N.V.
Psoriatic Arthritis
1 trial
Frequently asked questions
How many clinical projects does Janssen-Cilag International N.V have?
161 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.